Nitroxazepine
Nitroxazepine is a tricyclic antidepressant (TCA) that was developed in the 1960s but was never marketed. It is a derivative of imipramine where one of the benzene rings has been replaced with a pyridine ring.
Pharmacology[edit | edit source]
Nitroxazepine acts as a serotonin-norepinephrine reuptake inhibitor (SNRI) and also has other activities including antihistamine, anticholinergic, and antiadrenergic effects.
Chemistry[edit | edit source]
The chemical structure of nitroxazepine is similar to other tricyclic antidepressants but with a pyridine ring instead of a benzene ring. This gives it unique properties compared to other TCAs.
History[edit | edit source]
Nitroxazepine was developed in the 1960s as part of a series of compounds with potential antidepressant activity. However, it was never marketed, possibly due to its side effect profile or lack of efficacy compared to other drugs available at the time.
See also[edit | edit source]
Nitroxazepine Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Admin, Prab R. Tumpati, MD